- Home
- BMRN vs LINE Comparison
BMRN vs LINE Comparison
Compare BMRN & LINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- LINE
- Stock Information
- Founded
- BMRN 1996
- LINE 2012
- Country
- BMRN United States
- LINE United States
- Employees
- BMRN N/A
- LINE N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- LINE
- Sector
- BMRN Health Care
- LINE
- Exchange
- BMRN Nasdaq
- LINE NYSE
- Market Cap
- BMRN 13.7B
- LINE N/A
- IPO Year
- BMRN 1999
- LINE 2024
- Fundamental
- Price
- BMRN $71.44
- LINE $58.98
- Analyst Decision
- BMRN Buy
- LINE Buy
- Analyst Count
- BMRN 22
- LINE 17
- Target Price
- BMRN $94.00
- LINE $82.24
- AVG Volume (30 Days)
- BMRN 1.5M
- LINE 861.1K
- Earning Date
- BMRN 04-23-2025
- LINE 05-15-2025
- Dividend Yield
- BMRN N/A
- LINE 2.43%
- EPS Growth
- BMRN 153.71
- LINE N/A
- EPS
- BMRN 2.21
- LINE N/A
- Revenue
- BMRN $2,853,915,000.00
- LINE $5,340,000,000.00
- Revenue This Year
- BMRN $12.23
- LINE $5.92
- Revenue Next Year
- BMRN $9.90
- LINE $5.50
- P/E Ratio
- BMRN $32.37
- LINE N/A
- Revenue Growth
- BMRN 17.97
- LINE N/A
- 52 Week Low
- BMRN $60.63
- LINE $52.75
- 52 Week High
- BMRN $94.85
- LINE $89.85
- Technical
- Relative Strength Index (RSI)
- BMRN 55.89
- LINE N/A
- Support Level
- BMRN $69.60
- LINE N/A
- Resistance Level
- BMRN $73.18
- LINE N/A
- Average True Range (ATR)
- BMRN 1.64
- LINE 0.00
- MACD
- BMRN -0.15
- LINE 0.00
- Stochastic Oscillator
- BMRN 63.45
- LINE 0.00
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.